These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30930000)

  • 1. Atypical familial dysbetalipoproteinemia associated with high polygenic cholesterol and triglyceride scores treated with ezetimibe and evolocumab.
    Morise AP; Hegele RA
    J Clin Lipidol; 2019; 13(3):411-414. PubMed ID: 30930000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic transmission of isoapolipoprotein E phenotypes in a large kindred: relationship to dysbetalipoproteinemia and hyperlipidemia.
    Hazzard WR; Warnick GR; Utermann G; Albers JJ
    Metabolism; 1981 Jan; 30(1):79-88. PubMed ID: 7464557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Combined Dyslipidemia With a Complex Genetic Basis.
    Le R; Abbas M; McIntyre AD; Hegele RA
    J Investig Med High Impact Case Rep; 2019; 7():2324709619877050. PubMed ID: 31538826
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia.
    Rosenson RS; Jacobson TA; Preiss D; Djedjos CS; Dent R; Bridges I; Miller M
    Cardiovasc Drugs Ther; 2016 Jun; 30(3):305-13. PubMed ID: 27240673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia.
    Heidemann BE; Koopal C; Roeters van Lennep JE; Stroes ESG; Riksen NP; Mulder MT; -van der Zee LCVV; Blackhurst DM; Marais AD; Visseren FLJ
    J Clin Lipidol; 2023; 17(1):112-123. PubMed ID: 36384662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Familial Dysbetalipoproteinemia Based on the Lipid Abnormalities Driven by APOE2/E2 Genotype.
    Bea AM; Cenarro A; Marco-Bened V; Laclaustra M; Martn C; Ibarretxe D; Pint X; Arrobas T; Vials C; Civeira F; Olmos S
    Clin Chem; 2023 Feb; 69(2):140-148. PubMed ID: 36644927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
    Hopkins PN; Wu LL; Schumacher MC; Emi M; Hegele RM; Hunt SC; Lalouel JM; Williams RR
    Arterioscler Thromb; 1991; 11(5):1137-46. PubMed ID: 1680391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
    Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of lipoprotein profile in familial dysbetalipoproteinemia with gemfibrozil.
    Zhao SP; Smelt AH; Leuven JA; Vroom TF; van der Laarse A; van 't Hooft FM
    Am J Med; 1994 Jan; 96(1):49-56. PubMed ID: 8304363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Stuyt PM; Mol MJ; Stalenhoef AF; Demacker PN; Van 't Laar A
    Am J Med; 1990 Jan; 88(1N):42N-45N. PubMed ID: 2368763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
    Ziemer A; Göring HD
    Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
    Feussner G; Bommer J; Ziegler R
    Klin Wochenschr; 1990 Jan; 68(2):65-70. PubMed ID: 2319734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified diagnosis algorithm for dysbetalipoproteinemia.
    Paquette M; Bernard S; Blank D; Paré G; Baass A
    J Clin Lipidol; 2020; 14(4):431-437. PubMed ID: 32631794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexisting dysbetalipoproteinemia and familial hypercholesterolemia. Clinical and laboratory observations.
    Carmena R; Roy M; Roederer G; Minnich A; Davignon J
    Atherosclerosis; 2000 Jan; 148(1):113-24. PubMed ID: 10580177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment].
    Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T
    Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
    Heidemann BE; Koopal C; Baass A; Defesche JC; Zuurbier L; Mulder MT; Roeters van Lennep JE; Riksen NP; Boot C; Marais AD; Visseren FLJ
    Clin Genet; 2022 Oct; 102(4):253-261. PubMed ID: 35781703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
    Aljenedil S; Ruel I; Watters K; Genest J
    J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158-->Cys), E3-Leiden, and E2(Lys146-->Gln), and effects of treatment with simvastatin.
    Zhao SP; Smelt AH; Van den Maagdenberg AM; Van Tol A; Vroom TF; Gevers Leuven JA; Frants RR; Havekes LM; Van der Laarse A; Van 't Hooft FM
    Arterioscler Thromb; 1994 Nov; 14(11):1705-16. PubMed ID: 7947593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.